Company / Shares Outstanding
Fulcrum Therapeutics, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
63.4K
FY2025
5-year range
35.4K / 63.4K
FY2021-FY2025
Trend
+2.2%
vs FY2024
Sector context
#211 of 212
Health Care
What the data says
Among 212 Health Care companies, Fulcrum Therapeutics, Inc. is in the top 0% for shares outstanding. Shares Outstanding has increased for 7 consecutive years, from 1257.00 in FY2018 to 63355.00 in FY2025.
Based on SEC 10-K filings.
63355.00 in FY2025 with a 5-year CAGR of +20.1%.
Increased from 61310.00 to 63355.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 212This company 63.4K Sector average 306.7M
▼
-100.0% below sector average
Key checks
Key Insights
- Fulcrum Therapeutics, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 2.2% year-over-year.
- Ranks #211 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 63.4K | +2.2% |
| FY2024 | 62.0K | +1.1% |
| FY2023 | 61.3K | +36.3% |
| FY2022 | 45.0K | +27.2% |
| FY2021 | 35.4K | +39.5% |
| FY2020 | 25.4K | +129.5% |
| FY2019 | 11.0K | +778.8% |
| FY2018 | 1.3K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026